Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Case Series of Thrombosis with Thrombocytopenia Syndrome following COVID-19 vaccination—United States, December 2020–August 2021

Isaac See, Allison Lale, Paige Marquez, Michael B. Streiff, Allison P. Wheeler, Naomi K. Tepper, Emily Jane Woo, Karen R. Broder, Kathryn M. Edwards, Ruth Gallego, View ORCID ProfileAndrew I. Geller, Kelly A. Jackson, Shashi Sharma, Kawsar R. Talaat, Emmanuel B. Walter, Imo J. Akpan, Thomas L. Ortel, Shannon C. Walker, Jennifer C. Yui, Tom T. Shimabukuro, Adamma Mba-Jonas, John R. Su, David K. Shay
doi: https://doi.org/10.1101/2021.11.10.21266063
Isaac See
1Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta, GA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: isee@cdc.gov
Allison Lale
1Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta, GA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paige Marquez
1Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta, GA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael B. Streiff
2The Johns Hopkins University, Baltimore, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allison P. Wheeler
3Vanderbilt University Medical Center, Nashville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naomi K. Tepper
1Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta, GA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily Jane Woo
4Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen R. Broder
1Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta, GA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathryn M. Edwards
3Vanderbilt University Medical Center, Nashville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruth Gallego
1Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta, GA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew I. Geller
1Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta, GA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew I. Geller
Kelly A. Jackson
1Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta, GA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shashi Sharma
1Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta, GA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kawsar R. Talaat
2The Johns Hopkins University, Baltimore, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emmanuel B. Walter
5Duke University School of Medicine, Durham, NC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Imo J. Akpan
6Columbia University Irving Medical Center, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas L. Ortel
5Duke University School of Medicine, Durham, NC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shannon C. Walker
3Vanderbilt University Medical Center, Nashville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer C. Yui
2The Johns Hopkins University, Baltimore, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tom T. Shimabukuro
1Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta, GA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adamma Mba-Jonas
4Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John R. Su
1Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta, GA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David K. Shay
1Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta, GA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Thrombosis with thrombocytopenia syndrome (TTS) is a potentially life-threatening condition associated with adenoviral-vectored COVID-19 vaccination. TTS presents similarly to autoimmune heparin-induced thrombocytopenia. Twelve cases of cerebral venous sinus thrombosis following Janssen/Johnson & Johnson (Ad26.COV2.S) COVID-19 vaccination have been described.

Objective Describe surveillance data and reporting rates of TTS cases following COVID-19 vaccination.

Design Case series.

Setting United States

Patients Case-patients reported to the Vaccine Adverse Event Reporting System (VAERS) receiving COVID-19 vaccine from December 14, 2020 through August 31, 2021, with thrombocytopenia and thrombosis (excluding isolated ischemic stroke or myocardial infarction). If thrombosis was only in an extremity vein or pulmonary embolism, a positive enzyme-linked immunosorbent assay for anti-platelet factor 4 antibody was required.

Measurements Reporting rates (cases/million vaccine doses) and descriptive epidemiology.

Results 52 TTS cases were confirmed following Ad26.COV2.S (n=50) or mRNA-based COVID-19 (n=2) vaccination. TTS reporting rates were 3.55 per million (Ad26.COV2.S) and 0.0057 per million (mRNA-based COVID-19 vaccines). Median age of patients with TTS following Ad26.COV2.S vaccination was 43.5 years (range: 18–70); 70% were female. Both TTS cases following mRNA-based COVID-19 vaccination occurred in males aged >50 years. All cases following Ad26.COV2.S vaccination involved hospitalization including 32 (64%) with intensive care unit admission. Outcomes of hospitalizations following Ad26.COV2.S vaccination included death (12%), discharge to post-acute care (16%), and discharge home (72%).

Limitations Under-reporting and incomplete case follow-up.

Conclusion TTS is a rare but serious adverse event associated with Ad26.COV2.S vaccination. The different demographic characteristics of the two cases reported after mRNA-based COVID-19 vaccines and the much lower reporting rate suggest that these cases represent a background rate.

Funding Source CDC

Competing Interest Statement

Dr. Streiff reported receiving grants from Janssen for the Cassini clinical trial of rivaroxaban for prevention of cancer-associated thrombosis. He reported receiving personal fees from Janssen for serving on the advisory board for the Cassini trial; from Bayer, BristolMyersSquib and Dispersol for providing consultative advice; from Bayer for CME lectures; and from Pfizer for CME lectures and serving on their advisory board. Dr. Streiff reported receiving grants from the NIH-NHLBI for his study on missed doses in VTE prophylaxis, from AHRQ for his work on individualized feedback on VTE prophylaxis practices and from PCORI for his research on patient education to improve acceptance of VTE prophylaxis. Dr. Edwards has grant funding from NIH and CDC; has worked as a consultant to Bionet and IBM; and has been a member of the Data Safety and Monitoring Board for Sanofi, X-4 Pharma, Seqirus, Moderna, Pfizer, Merck, and Roche. Dr. Talaat reported receiving grants from Pfizer for serving as the site principal investigator for the Phase 3 adult COVID-19 vaccine study and the Phase 1-3 pediatric (under 12) COVID-19 vaccine study, both at Johns Hopkins University. She also reported receiving grants for serving as an investigator on the NIH (COVPN) AstraZeneca COVID-19 vaccine trial in adults. Dr. Walter is a principal investigator for Pfizer-funded studies of COVID-19 vaccine (Adults and Children) and an NIH-funded study of the AstraZeneca COVID-19 vaccine (Adults), a co-investigator for a vaccine study funded by Moderna, and a member of an advisory board for Vaxcyte. Dr. Ortel has received research support from Instrumentation Laboratory, Stago, and Siemens, related to laboratory analysis of coagulation disorders, and from the Centers for Disease Control and Prevention, related to surveillance for venous thromboembolism. Dr. Ortel has also provided consultative services to Instrumentation Laboratory for compensation. Dr. Ortel has also received honoraria for contributions to UpToDate on the diagnosis and management of antiphospholipid syndrome.

Funding Statement

This work was supported by the Centers for Disease Control and Prevention Clinical Immunization Safety Assessment (CISA] project contracts 200-2012-53664-0005 to Johns Hopkins University, 200-2012-50430-0005 to Vanderbilt University Medical Center, 200-2012-53663-0011 to Duke University, and 200-2012-53665-0005 to Columbia University.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Human subjects advisors of Centers for Disease Control and Prevention gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Due to legal restrictions related to confidentiality, the original data are not available to the public.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Back to top
PreviousNext
Posted November 14, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Case Series of Thrombosis with Thrombocytopenia Syndrome following COVID-19 vaccination—United States, December 2020–August 2021
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Case Series of Thrombosis with Thrombocytopenia Syndrome following COVID-19 vaccination—United States, December 2020–August 2021
Isaac See, Allison Lale, Paige Marquez, Michael B. Streiff, Allison P. Wheeler, Naomi K. Tepper, Emily Jane Woo, Karen R. Broder, Kathryn M. Edwards, Ruth Gallego, Andrew I. Geller, Kelly A. Jackson, Shashi Sharma, Kawsar R. Talaat, Emmanuel B. Walter, Imo J. Akpan, Thomas L. Ortel, Shannon C. Walker, Jennifer C. Yui, Tom T. Shimabukuro, Adamma Mba-Jonas, John R. Su, David K. Shay
medRxiv 2021.11.10.21266063; doi: https://doi.org/10.1101/2021.11.10.21266063
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Case Series of Thrombosis with Thrombocytopenia Syndrome following COVID-19 vaccination—United States, December 2020–August 2021
Isaac See, Allison Lale, Paige Marquez, Michael B. Streiff, Allison P. Wheeler, Naomi K. Tepper, Emily Jane Woo, Karen R. Broder, Kathryn M. Edwards, Ruth Gallego, Andrew I. Geller, Kelly A. Jackson, Shashi Sharma, Kawsar R. Talaat, Emmanuel B. Walter, Imo J. Akpan, Thomas L. Ortel, Shannon C. Walker, Jennifer C. Yui, Tom T. Shimabukuro, Adamma Mba-Jonas, John R. Su, David K. Shay
medRxiv 2021.11.10.21266063; doi: https://doi.org/10.1101/2021.11.10.21266063

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (431)
  • Anesthesia (99)
  • Cardiovascular Medicine (943)
  • Dentistry and Oral Medicine (178)
  • Dermatology (109)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (419)
  • Epidemiology (8971)
  • Forensic Medicine (4)
  • Gastroenterology (418)
  • Genetic and Genomic Medicine (1938)
  • Geriatric Medicine (190)
  • Health Economics (400)
  • Health Informatics (1323)
  • Health Policy (657)
  • Health Systems and Quality Improvement (517)
  • Hematology (212)
  • HIV/AIDS (416)
  • Infectious Diseases (except HIV/AIDS) (10772)
  • Intensive Care and Critical Care Medicine (571)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (221)
  • Neurology (1819)
  • Nursing (108)
  • Nutrition (271)
  • Obstetrics and Gynecology (351)
  • Occupational and Environmental Health (469)
  • Oncology (992)
  • Ophthalmology (296)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (576)
  • Pharmacology and Therapeutics (275)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1892)
  • Public and Global Health (4111)
  • Radiology and Imaging (674)
  • Rehabilitation Medicine and Physical Therapy (364)
  • Respiratory Medicine (548)
  • Rheumatology (224)
  • Sexual and Reproductive Health (190)
  • Sports Medicine (177)
  • Surgery (207)
  • Toxicology (38)
  • Transplantation (109)
  • Urology (80)